Compass Therapeutics
phase data | Compass Therapeutics
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
6 of 20
Similar slides by Compass Therapeutics
See diffirences between slides (animation)
Investor Presentation
May 2023
phase data responses achieved across multiple subclasses as of compass | Compass Therapeutics
Investor Presentation
February 2023
phase data responses achieved across multiple subclasses as of | Compass Therapeutics
Investor Presentation
May 2022
phase waterfall a | Compass Therapeutics
Investor Presentation
May 2022
phase waterfall a | Compass Therapeutics
Related slides by other companies
BioAtla
Investor Presentation
January 2024
phase cab confirmed responses and stable disease among evaluable patients | BioAtla
RenovoRx
IPO
August 2021
promising data from phase and observational registry studies advanced clinical development program to phase median overall survival gem alone | RenovoRx
Erasca
Investor Presentation
November 2023
phase data showed is preferable to dosing simulations suggest bid dosing may improve profiles and even more | Erasca
Aeglea BioTherapeutics
Investor Presentation
October 2023
cash and anticipated milestones | Aeglea BioTherapeutics
Other recent decks by Compass Therapeutics
See all presentations (6 decks)
Investor Presentation
May 2023
Investor Presentation
February 2023
Investor Presentation
May 2022
Investor Presentation
May 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io